Bgm (BGM) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $8.65, +0.70% vs the prior close of $8.59.
- Volume 2.79K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BGM rises 0.7% to $8.65. Closed at $8.65, +0.70% vs the prior close of $8.59. Day range $8.65–$8.94, opened at $8.94.
BGM daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — BGM rises 0.7% to $8.65
- Closed at $8.65, +0.70% vs the prior close of $8.59. Day range $8.65–$8.94, opened at $8.94.
- Volume was 2.79K shares, 0.4x its 50-day average of 7.65K — lighter than usual.
- Price is +2.2% vs its 50-day average ($8.46) and -64.5% vs its 200-day average ($24.37).
- 52-week range $6.45–$303.00; today's close sits at 1% of that range, 97.1% below the 52-week high.
Oct 15, 2026 — BGM slides 10.1% to $8.59
- Closed at $8.59, -10.05% vs the prior close of $9.55. Day range $8.59–$8.59, opened at $8.59.
- Volume was 700 shares, 0.1x its 50-day average of 7.67K — lighter than usual.
- Price is +1.5% vs its 50-day average ($8.47) and -65.5% vs its 200-day average ($24.91).
- 52-week range $6.45–$303.00; today's close sits at 1% of that range, 97.2% below the 52-week high.
Oct 14, 2026 — BGM slides 8.9% to $9.55 on 1.8x normal volume
- Closed at $9.55, -8.87% vs the prior close of $10.48. Day range $9.55–$10.29, opened at $10.10.
- Volume was 13.50K shares, 1.8x its 50-day average of 7.42K — unusually heavy trading.
- Price is +12.7% vs its 50-day average ($8.47) and -62.5% vs its 200-day average ($25.48).
- 52-week range $6.45–$303.00; today's close sits at 1% of that range, 96.8% below the 52-week high.
Oct 13, 2026 — BGM rises 2.7% to $10.48
- Closed at $10.48, +2.75% vs the prior close of $10.20. Day range $9.56–$10.48, opened at $9.56.
- Volume was 5.30K shares, 0.7x its 50-day average of 7.38K.
- Price is +23.8% vs its 50-day average ($8.46) and -59.8% vs its 200-day average ($26.08).
- 52-week range $6.45–$303.00; today's close sits at 1% of that range, 96.5% below the 52-week high.
Oct 12, 2026 — BGM slides 5.1% to $10.20
- Closed at $10.20, -5.12% vs the prior close of $10.75. Day range $9.60–$10.74, opened at $10.74.
- Volume was 9.00K shares, 1.2x its 50-day average of 7.23K.
- Price is +21.0% vs its 50-day average ($8.43) and -61.7% vs its 200-day average ($26.67).
- 52-week range $6.45–$303.00; today's close sits at 1% of that range, 96.6% below the 52-week high.
Oct 9, 2026 — BGM jumps 7.9% to $10.75, a 3-month high
- Closed at $10.75, +7.93% vs the prior close of $9.96. Day range $9.95–$10.78, opened at $9.95.
- Volume was 3.30K shares, 0.5x its 50-day average of 7.18K — lighter than usual.
- Price is +28.1% vs its 50-day average ($8.39) and -60.6% vs its 200-day average ($27.26).
- 52-week range $6.45–$303.00; today's close sits at 1% of that range, 96.5% below the 52-week high.
Oct 8, 2026 — BGM jumps 6.1% to $9.96, a 1-month high
- Closed at $9.96, +6.07% vs the prior close of $9.39. Day range $9.38–$9.96, opened at $9.38.
- Volume was 1.40K shares, 0.2x its 50-day average of 7.16K — lighter than usual.
- Price is +19.4% vs its 50-day average ($8.34) and -64.3% vs its 200-day average ($27.87).
- 52-week range $6.45–$311.40; today's close sits at 1% of that range, 96.8% below the 52-week high.
Oct 7, 2026 — BGM dips 2.7% to $9.39
- Closed at $9.39, -2.69% vs the prior close of $9.65. Day range $8.68–$9.61, opened at $9.47.
- Volume was 1.80K shares, 0.3x its 50-day average of 7.14K — lighter than usual.
- Price is +12.9% vs its 50-day average ($8.31) and -67.0% vs its 200-day average ($28.47).
- 52-week range $6.45–$311.40; today's close sits at 1% of that range, 97.0% below the 52-week high.
Oct 6, 2026 — BGM jumps 3.2% to $9.65, a 1-month high, 7 up days in a row
- Closed at $9.65, +3.21% vs the prior close of $9.35. Day range $9.17–$10.08, opened at $9.17.
- Volume was 7.80K shares, 1.1x its 50-day average of 7.01K.
- Price is +16.3% vs its 50-day average ($8.30) and -66.9% vs its 200-day average ($29.18).
- 52-week range $6.45–$311.40; today's close sits at 1% of that range, 96.9% below the 52-week high.
- That makes 7 straight gains.
Oct 5, 2026 — BGM ends flat (+0.1%) to $9.35, a 1-month high, 6 up days in a row
- Closed at $9.35, +0.11% vs the prior close of $9.34. Day range $8.36–$9.35, opened at $9.28.
- Volume was 4.60K shares, 0.7x its 50-day average of 6.94K.
- Price is +13.0% vs its 50-day average ($8.27) and -68.7% vs its 200-day average ($29.88).
- 52-week range $6.45–$317.10; today's close sits at 1% of that range, 97.1% below the 52-week high.
- That makes 6 straight gains.
Oct 2, 2026 — BGM jumps 19.4% to $9.34, a 1-month high on 6.2x normal volume
- Closed at $9.34, +19.44% vs the prior close of $7.82. Day range $7.70–$9.91, opened at $7.70.
- Volume was 38.50K shares, 6.2x its 50-day average of 6.19K — unusually heavy trading.
- Price is +13.0% vs its 50-day average ($8.26) and -69.5% vs its 200-day average ($30.58).
- 52-week range $6.45–$317.10; today's close sits at 1% of that range, 97.1% below the 52-week high.
- That makes 5 straight gains.
BGM latest news & SEC filings
Every SEC filing by or about BGM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 24, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 28, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 11, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 28, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 21, 2026 · Form 20-F — Annual report from a foreign company (20-F)
Annual report from a foreign company (20-F)
Fiscal year ended Sep 30, 2025:
- Revenue: $37.92M (prior year $25.10M) (+51.1% vs Sep 30, 2024)
- Net income: -$19.94M (prior year -$1.44M) (loss widened vs Sep 30, 2024)
- Diluted EPS: -$0.18 (prior year -$0.20) (loss narrowed vs Sep 30, 2024)
Jul 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade BGM
- How much it moves: over the last 20 sessions the average daily move was 4.26% (largest 19.4%). That is a volatile stock.
- Liquidity: about 7.50K shares (≈$64.88K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $8.65 vs a range of $6.45–$303.00 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:30 on Oct 1, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Sep 24, 2026; 6-K Sep 8, 2026; 6-K Aug 28, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
BGM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 8.94 | 8.94 | 8.65 | 8.65 | 2.79K |
| Oct 15, 2026 | 8.59 | 8.59 | 8.59 | 8.59 | 700 |
| Oct 14, 2026 | 10.10 | 10.29 | 9.55 | 9.55 | 13.50K |
| Oct 13, 2026 | 9.56 | 10.48 | 9.56 | 10.48 | 5.30K |
| Oct 12, 2026 | 10.74 | 10.74 | 9.60 | 10.20 | 9.00K |
| Oct 9, 2026 | 9.95 | 10.78 | 9.95 | 10.75 | 3.30K |
| Oct 8, 2026 | 9.38 | 9.96 | 9.38 | 9.96 | 1.40K |
| Oct 7, 2026 | 9.47 | 9.61 | 8.68 | 9.39 | 1.80K |
| Oct 6, 2026 | 9.17 | 10.08 | 9.17 | 9.65 | 7.80K |
| Oct 5, 2026 | 9.28 | 9.35 | 8.36 | 9.35 | 4.60K |
| Oct 2, 2026 | 7.70 | 9.91 | 7.70 | 9.34 | 38.50K |
| Oct 1, 2026 | 7.64 | 10.80 | 6.45 | 7.82 | 38.60K |
| Sep 30, 2026 | 7.74 | 8.25 | 7.23 | 7.56 | 4.23K |
| Sep 29, 2026 | 7.47 | 8.34 | 7.20 | 7.47 | 4.74K |
| Sep 28, 2026 | 7.20 | 7.50 | 6.90 | 7.32 | 1.52K |
| Sep 25, 2026 | 7.32 | 8.34 | 6.90 | 7.20 | 6.32K |
| Sep 24, 2026 | 7.80 | 7.80 | 7.47 | 7.47 | 1.16K |
| Sep 23, 2026 | 7.68 | 7.95 | 7.50 | 7.65 | 2.34K |
| Sep 22, 2026 | 7.80 | 7.95 | 7.38 | 7.74 | 470 |
| Sep 21, 2026 | 7.47 | 8.10 | 7.47 | 7.68 | 1.95K |
About Bgm
Bgm (BGM) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CHENGDU. State of incorporation: Cayman Islands. Fiscal year ends September 30. SEC CIK 1779578.
BGM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Zefei Lou | Director | May 14, 2026 |
| Waihua Xu | Director | May 14, 2026 |
| Lin (Henry) Zhang | Director | Apr 13, 2026 |
| Yuehua Ren | Director | May 14, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Yaxuan Zhai | Chief Financial Officer | May 14, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
BGM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
BGM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on BGM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.